Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,209 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Completed

A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain

NCT01266967

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +16 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Ann Arbor, Michigan, United States
View all 24 locations
View Trial Details
Completed

Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF Inhibitor

NCT01037127

Conditions
Cancer, Melanoma, Neoplasms, +10 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

NCT01014351

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Northeast Georgia Medical Center Gainesville, Georgia, United States
  • Oncology Hematology of SW Indiana Evansville, Indiana, United States
  • Hematology Oncology Clinic, LLP Baton Rouge, Louisiana, United States
View Trial Details
Completed

Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

NCT00356460

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +22 more
Locations
  • National Cancer Institute (NCI) Bethesda, Maryland, United States
  • Dana Farber/Harvard Cancer Center, Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Massachusetts General Hospital Cambridge, Massachusetts, United States
View Trial Details

Related conditions